Literature DB >> 13319488

The action of heparin in the prevention of prothrombin conversion.

A S DOUGLAS.   

Abstract

Entities:  

Keywords:  HEPARIN/effects; PROTHROMBIN/physiology

Mesh：

Substances：

Year:  1956        PMID： 13319488      PMCID： PMC438841          DOI： 10.1172/JCI103306

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  12 in total

1.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.

Authors:  O D RATNOFF; J E COLOPY
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

2.  Assessment of clotting efficiency.

Authors:  R BIGGS
Journal:  Br Med Bull       Date:  1955       Impact factor: 4.291

3.  Plasma thromboplastin antecedent (PTA) deficiency; clinical, coagulation, therapeutic and hereditary aspects of a new hemophilia-like disease.

Authors:  R L ROSENTHAL; O H DRESKIN; N ROSENTHAL
Journal:  Blood       Date:  1955-02       Impact factor: 22.113

4.  Heparin and thromboplastin.

Authors:  R L MACMILLAN; K W BROWN
Journal:  J Lab Clin Med       Date:  1954-09

5.  A possible fourth plasma thromboplastin component.

Authors:  T H SPAET; P M AGGELER; B G KINSELL
Journal:  J Clin Invest       Date:  1954-08       Impact factor: 14.808

6.  The action of thromboplastic substances.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE
Journal:  J Physiol       Date:  1953-12-29       Impact factor: 5.182

7.  The formation of thromboplastin in human blood.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE
Journal:  J Physiol       Date:  1953-01       Impact factor: 5.182

8.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

9.  The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

10.  The consumption of some components involved in physiological blood coagulation.

Authors:  A S DOUGLAS; R BIGGS
Journal:  Glasgow Med J       Date:  1953-08
View more
  6 in total

1.  Effect of Polybrene on blood coagulation of dogs.

Authors:  K E KARLSON; B LERNER
Journal:  Ann Surg       Date:  1962-12       Impact factor: 12.969

2.  Hematological and pathological studies of the effects of four-hour perfusion level heparinization on dogs.

Authors:  R T DOMINGO; B LERNER; R R CAPPELLETTI; N S AMER; K E KARLSON; J H STUCKEY
Journal:  Ann Surg       Date:  1962-03       Impact factor: 12.969

3.  Heparin-like anticoagulant occurring in association with chronic nephritis.

Authors:  A I CETINGIL; O N ULUTIN; M KARACA
Journal:  Br Med J       Date:  1959-07-11

4.  The effect of heparin on the early stages of blood coagulation.

Authors:  J R O'BRIEN
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

5.  Vasculas complications in nephrotic syndrome: relationship to steroid therapy and accelerated thromboplastin generation.

Authors:  A P Mukherjee; B H Toh; G L Chan; K S Lau; J C White
Journal:  Br Med J       Date:  1970-10-31

6.  Effect of dextran sulphates on thrombin activity.

Authors:  K Suzuki; S Hashimoto
Journal:  J Clin Pathol       Date:  1979-05       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.